Metrics

  • citations in SCIndeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[]
  • visits in previous 30 days:4
  • full-text downloads in 30 days:1

Contents

article: 3 from 205  
Back back to result list
2022, vol. 13, iss. 1, pp. 95-104
Post-chemotherapy cognitive dysfunction in women with breast cancer
University of East Sarajevo, Faculty of Medicine, Foča, Republic of Srpska, B&H

emailgoricavuksanovic@gmail.com
Keywords: cancer-related cognitive impairment; breast cancer; women
Abstract
Cancer-related cognitive dysfunction is an important clinical problem that can interfere with the daily functioning, work productivity, childcare, and other responsibilities of women with a history of breast cancer. Risks of cancer-related cognitive impairment include cancer and cancer treatment, as well as patient-related vulnerabilities. There is no established standard of neuroprotective care or treatment for breast cancer-related cognitive impairment.
References
Abraham, J., Haut, M.W., Moran, M.T., Filburn, S., Lemiuex, S., Kuwabara, H. (2008) Adjuvant chemotherapy for breast cancer: Effects on cerebral white matter seen in diffusion tensor imaging. Clin Breast Cancer, 8(1): 88-91
Ahles, T., Root, J.C., EL, R. (2012) Cancerand Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science. J Clin Oncol, 30(30): 3675-86
Berndt, U., Leplow, B., Schoenfeld, R., Lantzsch, T., Grosse, R., Thomssen, C. (2016) Memory and spatial cognition in breast cancer patients undergoing adjuvant endocrine therapy. Breast Care (Basel), 11(4): 240-6
Chen, X., He, X., Tao, L., Cheng, H., Li, J., Zhang, J., et al. (2017) The attention network changes in breast cancer patients receiving neoadjuvant chemotherapy: Evidence from an arterial spin labeling perfusion study. Sci Rep, 7: 42684
Cimprich, B., Reuter-Lorenz, P., Nelson, J., Clark, P.M., Therrien, B., Normolle, D., Berman, M.G., Hayes, D.F., Noll, D.C., Peltier, S., Welsh, R.C. (2010) Prechemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology, 32(3): 324-331
de Ruiter, M.B., Reneman, L., Boogerd, W., Veltman, D.J., Caan, M., Douaud, G., et al. (2011) Late effects of highdose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Hum Brain Mapp, 33(12): 2971-83
de Ruiter, M.B., Reneman, L., Boogerd, W., Veltman, D.J., van Dam, F.S.A.M., Nederveen, A.J., Boven, E., Schagen, S.B. (2011) Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32(8): 1206-1219
Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., den Stock, J.V., et al. (2011) Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired functioning in breast cancer patients. Hum Brain Mapp, 32(3): 480-93
Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., van Hecke, W., Verhoeven, J.S., Christiaens, M., Vandenberghe, J., Vandenbulcke, M., Sunaert, S. (2012) Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning. Journal of Clinical Oncology, 30(3): 274-281
Dimitrova, N., Znaor, A., Agius, D., Eser, S., Sekerija, M., Ryzhov, A., Primic-Žakelj, M., Coebergh, J.W., Agius, D., Coza, D., Gheorghiu, R., Diba, C.S., Pavlou, P., Demetriou, A., Eser, S. (2017) Breast cancer in South-Eastern European countries since 2000: Rising incidence and decreasing mortality at young and Middle Ages. European Journal of Cancer, 83: 43-55
Ferguson, R.J., Mcdonald, B.C., Saykin, A.J., Ahles, T.A. (2007) Brain Structure and Function Differences in Monozygotic Twins: Possible Effects of Breast Cancer Chemotherapy. Journal of Clinical Oncology, 25(25): 3866-3870
Ganz, P.A., Kwan, L., Castellon, S.A., Oppenheim, A., Bower, J.E., Silverman, D.H.S., Cole, S.W., Irwin, M.R., Ancoli-Israel, S., Belin, T.R. (2013) Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance. JNCI: Journal of the National Cancer Institute, 105(11): 791-801
Henneghan, A., Stuifbergen, A., Becker, H., Kesler, S., King, E. (2018) Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion. J Cancer Surviv, 12(2): 224-33
Hermelink, K., Bühner, M., Sckopke, P., Neufeld, F., Kaste, J., Voigt, V., et al. (2017) Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients. J Natl Cancer Inst, 109(10
Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., et al. (2007) Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109(1): 146-56
Jung, M.S., Zhang, M., Askren, M.K., Berman, M.G., Peltier, S., Hayes, D.F., et al. (2017) Cognitive dysfunction and symptom burden in women treated for breast cancer: A prospective behavioral and fMRI analysis. Brain Imaging Behav, 11(1): 86-97
Kam, J.W.Y., Brenner, C.A., Handy, T.C., Boyd, L.A., Liu-Ambrose, T., Lim, H.J., et al. (2016) Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: An electrophysiological study. Clin Neurophysiol, 127(1):369-78
Kesler, S.R., Kent, J.S., O'hara, R. (2011) Prefrontal Cortex and Executive Function Impairments in Primary Breast Cancer. Archives of Neurology, 68(11): 1447-53
Kesler, S.R., Rao, A., Blayney, D.W., Oakley-Girvan, I.A., Karuturi, M., Palesh, O. (2017) Predicting Long-Term Cognitive Outcome Following Breast Cancer with Pre-Treatment Resting State fMRI and Random Forest Machine Learning. Front Hum Neurosci, 11: 555
Kesler, S.R., Bennett, F. C., Mahaffey, M.L., Spiegel, D. (2009) Regional Brain Activation during Verbal Declarative Memory in Metastatic Breast Cancer. Clinical Cancer Research, 15(21): 6665-6673
Khasraw, M., Posner, J.B. (2010) Neurological complications of systemic cancer. Lancet Neurology, 9(12): 1214-1227
Koppelmans, V., de Ruiter, M.B., van der Lijn, F., Boogerd, W., Seynaeve, C., van der Lugt, A., et al. (2012) Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat, 132(3): 1099-106
Lange, M., Heutte, N., Noal, S., Rigal, O., Kurtz, J.E., Lévy, C., Allouache, D., Rieux, C., Lefel, J., Clarisse, B., Leconte, A., Veyret, C., Barthélémy, P., Longato, N., Tron, L. (2019) Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer. Oncologist, 24(1): 62-68
Levitt, H.M. (2018) How to conduct a qualitative meta-analysis: Tailoring methods to enhance methodological integrity. Psychother Res, 28(3): 367-78
Li, X., Chen, H., Lv, Y., Chao, H.H., Gong, L., Li, C.S.R., et al. (2018) Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients. Sci Rep, 8(1): 13801
Mcdonald, B.C., Conroy, S.K., Ahles, T.A., West, J.D., Saykin, A.J., et al. (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study. Breast Cancer Res Treat, 123(3): 819-28
Mcdonald, B.C., Conroy, S.K., Ahles, T.A., West, J.D., Saykin, A.J. (2012) Alterations in Brain Activation During Working Memory Processing Associated With Breast Cancer and Treatment: A Prospective Functional Magnetic Resonance Imaging Study. Journal of Clinical Oncology, 30(20): 2500-2508
Menning, S., de Ruiter, M.B., Kieffer, J.M., van Rentergem, J.A., Veltman, D.J., Fruijtier, A., et al. (2016) Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy: Results From a Longitudinal Study. J Pain Symptom Manage, 52(4): 560-9.e1
Menning, S., de Ruiter, M.B., Veltman, D.J., Boogerd, W., Oldenburg, H.S.A., Reneman, L., et al. (2017) Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. PLoS One, 12(3): e0171724
Miao, H., Li, J., Hu, S., He, X., Partridge, S.C., Ren, J., et al. (2016) Long-term cognitive impairment of breast cancer patients after chemotherapy: A functional MRI study. Eur J Radiol, 85(6): 1053-7
Paquet, L., Verma, S., Collins, B., Chinneck, A., Bedard, M., Song, X. (2018) Testing a novel account of the dissociation between self-reported memory problems and memory performance in chemotherapy-treated breast cancer survivors. Psychooncology, 27(1): 171-7
Ramalho, M., Fontes, F., Ruano, L., Pereira, S., Lunet, N. (2017) Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study. Breast, 32: 173-8
Scherling, C., Collins, B., Mackenzie, J., Bielajew, C., Smith, A. (2011) Pre-Chemotherapy Differences in Visuospatial Working Memory in Breast Cancer Patients Compared to Controls: An fMRI Study. Frontiers in Human Neuroscience, 5: 122
Silverman, D.H.S., Dy, C.J., Castellon, S.A., Lai, J., Pio, B.S., Abraham, L., Waddell, K., Petersen, L., Phelps, M.E., Ganz, P.A. (2007) Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Research and Treatment, 103(3): 303-311
Simó, M., Rifà-Ros, X., Rodriguez-Fornells, A., Bruna, J. (2013) Chemobrain: A systematic review of structural and functional neuroimaging studies. Neuroscience & Biobehavioral Reviews, 37(8): 1311-1321
Torre, L.A., Siegel, R.L., Ward, E.M., Jemal, A. (2016) Global Cancer Incidence and Mortality Rates and Trends: An Update. Cancer Epidemiology, Biomarkers & Prevention, 25(1): 16-27
Yoshikawa, E., Matsuoka, Y., Inagaki, M., Nakano, T., Akechi, T., Kobayakawa, M., et al. (2005) No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Res Treat, 92(1): 81-4
Zheng, F., Cao, P., Zhou, J., Li, C., Norris, J. (2020) Study on Neurologic and Cognitive Dysfunction in Breast Cancer Patients undergoing Chemotherapy with RS fMRI Imaging. World Neurosurg, S1878-8750(20)32280-4
 

About

article language: English
document type: Review Paper
DOI: 10.5937/BII2201095V
received: 04/05/2022
accepted: 23/06/2022
published in SCIndeks: 16/09/2022
Creative Commons License 4.0

Related records

No related records